background


Product Information:

ICG-001

ICG-001 is an inhibitor of β-catenin/TCF mediated transcription and specifically binding to cyclic AMP response element-binding protein with an IC50 of 3 μM.

Cat. No.: EX-A1745    Purity: >98%
Chemical
Chemical structure of ICG-001


For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
250mg585In-stock
500mg800In-stock
1g1200In-stock
2g1900In-stock
5g3800In-stock
10g5760In-stock


CAS No.847591-62-2
Purity>98%
FormulaC33H32N4O4
Mol Weight548.6316
AppearanceWhite to off-white solid powder
SolubilitySoluble in DMSO
Shelf Life>3 years if stored properly
StoragePowder -20℃ 3 years; In solvent -20℃ 1 month;
ShippingShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
 
 
Reference:  

[1]. Yan D, et al, Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. J Biol Chem, 2012, 287(11), 8598-8612.

[2]. Henderson WR Jr, et al, Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci USA, 2010, 107(32), 14309-14314.

[3]. Emami KH, et al. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci USA, 2004, 101(34), 12682-12687.

[4]. Liu Y, et al. ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population. J Exp Clin Cancer Res. 2017 Sep 11;36(1):125.

CoACoA of ICG-001
Smiles:[H][C@]12CN(CC3=C4C=CC=CC4=CC=C3)C(=O)[C@H](CC3=CC=C(O)C=C3)N1C(=O)CCN2C(=O)NCC1=CC=CC=C1

KEYWORDS: buy ICG-001 | ICG-001 supplier | purchase | cost | manufacturer | order | distributor | buy 847591-62-2 | 847591-62-2 supplier